Skip to content
10-Q

Quarterly Report

AEON Biopharma, Inc. AEON

0001837607-26-000042

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 26.31M sh
Shares Diluted Q1 2026 · Mar 31, 2026 40.61M sh
Shares Diluted Q1 2026 · Mar 31, 2025 3.98M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$2.64M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$7.91M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $6.24M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $3.01M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$16.75M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$55.03M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$11.32M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$28.57M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.67M
Current Liabilities Q1 2026 · Dec 31, 2025 $6.9M
Total Liabilities Q1 2026 · Mar 31, 2026 $25.38M
Total Liabilities Q1 2026 · Dec 31, 2025 $60.59M
Current Assets Q1 2026 · Mar 31, 2026 $6.63M
Current Assets Q1 2026 · Dec 31, 2025 $3.4M
Total Assets Q1 2026 · Mar 31, 2026 $8.63M
Total Assets Q1 2026 · Dec 31, 2025 $5.56M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.29
Eps Diluted Q1 2026 · Mar 31, 2025 $2.28
Eps Basic Q1 2026 · Mar 31, 2026 −$0.29
Eps Basic Q1 2026 · Mar 31, 2025 $2.28
Sga Expense Q1 2026 · Mar 31, 2026 $3.9M
Sga Expense Q1 2026 · Mar 31, 2025 $3.13M
Rd Expense Q1 2026 · Mar 31, 2026 $2.03M
Rd Expense Q1 2026 · Mar 31, 2025 $825K
Net Income Q1 2026 · Mar 31, 2026 −$11.79M
Net Income Q1 2026 · Mar 31, 2025 $9.1M
Operating Income Q1 2026 · Mar 31, 2026 −$5.93M
Operating Income Q1 2026 · Mar 31, 2025 −$462K
Capex Q1 2026 · Mar 31, 2025 $4K